Kirsten Gillibrand actually said...

"So if you find that degradation was higher than you expected, will you then go back and challenge other assumptions you made in the review for relicensing?"

"I think it is very unwise and I think it is unsafe."

"When Turing Pharmaceuticals was establishing its pricing plan for the drug Daraprim, you raised concerns internally about the proposed price increase."

"Will you commit to working with my office and New York State to ensure that the Army Corps will not propose disposal sites that in any way would negatively impact the environmental quality of the Soun..."